Ranju Ralhan

7.4k total citations
155 papers, 6.1k citations indexed

About

Ranju Ralhan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ranju Ralhan has authored 155 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 62 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Ranju Ralhan's work include Cancer-related gene regulation (29 papers), Epigenetics and DNA Methylation (26 papers) and Cancer-related Molecular Pathways (25 papers). Ranju Ralhan is often cited by papers focused on Cancer-related gene regulation (29 papers), Epigenetics and DNA Methylation (26 papers) and Cancer-related Molecular Pathways (25 papers). Ranju Ralhan collaborates with scholars based in India, Canada and United States. Ranju Ralhan's co-authors include Jasbir Kaur, Ajay Matta, Anurag Srivastava, Nootan Kumar Shukla, Meera Mathur, Sameer Mirza, Gayatri Sharma, K. W. Michael Siu, Chandra Prakash Prasad and Rajinder Parshad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ranju Ralhan

155 papers receiving 6.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ranju Ralhan 3.9k 2.1k 1.3k 535 522 155 6.1k
Vivian Wai Yan Lui 3.5k 0.9× 2.5k 1.2× 1.7k 1.4× 568 1.1× 951 1.8× 112 6.9k
Carter Van Waes 4.5k 1.2× 3.8k 1.8× 2.7k 2.1× 600 1.1× 738 1.4× 155 8.9k
Zhong Chen 2.4k 0.6× 1.7k 0.8× 1.5k 1.2× 261 0.5× 345 0.7× 74 4.2k
M. Radhakrishna Pillai 2.0k 0.5× 914 0.4× 719 0.6× 265 0.5× 186 0.4× 138 3.8k
Moulay A. Alaoui‐Jamali 3.1k 0.8× 1.3k 0.6× 792 0.6× 163 0.3× 133 0.3× 138 4.8k
Mitsuhiko Osaki 4.1k 1.1× 1.3k 0.6× 1.8k 1.4× 955 1.8× 64 0.1× 158 6.8k
Prabhudas S. Patel 1.5k 0.4× 558 0.3× 571 0.5× 274 0.5× 319 0.6× 135 2.8k
Alexander T.H. Wu 2.6k 0.7× 1.1k 0.5× 1.1k 0.9× 529 1.0× 149 0.3× 170 5.1k
Kaori Shima 2.3k 0.6× 3.2k 1.5× 1.3k 1.0× 640 1.2× 85 0.2× 81 5.7k
Pei‐Yi Chu 2.6k 0.7× 1.5k 0.7× 1.1k 0.9× 453 0.8× 63 0.1× 210 4.7k

Countries citing papers authored by Ranju Ralhan

Since Specialization
Citations

This map shows the geographic impact of Ranju Ralhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranju Ralhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranju Ralhan more than expected).

Fields of papers citing papers by Ranju Ralhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranju Ralhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranju Ralhan. The network helps show where Ranju Ralhan may publish in the future.

Co-authorship network of co-authors of Ranju Ralhan

This figure shows the co-authorship network connecting the top 25 collaborators of Ranju Ralhan. A scholar is included among the top collaborators of Ranju Ralhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranju Ralhan. Ranju Ralhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Srivastava, Gunjan, Ajay Matta, Guodong Fu, et al.. (2015). Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy. Molecular Oncology. 9(8). 1720–1735. 32 indexed citations
3.
Srivastava, Gunjan, et al.. (2015). Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas. PLoS ONE. 10(2). e0107586–e0107586. 4 indexed citations
4.
Srivastava, Gunjan, Lawrence Kashat, Ajay Matta, et al.. (2014). Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients. BMC Cancer. 14(1). 726–726. 10 indexed citations
5.
Kashat, Lawrence, Tada Kunavisarut, Dae Hyun Kim, et al.. (2012). An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma. PLoS ONE. 7(9). e42893–e42893. 16 indexed citations
6.
Sharma, Gayatri, Sameer Mirza, Rajinder Parshad, Siddartha Datta Gupta, & Ranju Ralhan. (2012). DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumor Biology. 33(6). 1837–1843. 36 indexed citations
7.
Macha, Muzafar A., Ajay Matta, Shyam S. Chauhan, K. W. Michael Siu, & Ranju Ralhan. (2011). Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells. PLoS ONE. 6(2). e14728–e14728. 21 indexed citations
8.
Matta, Ajay, Leroi V. DeSouza, Ranju Ralhan, & K. W. Michael Siu. (2010). Small Interfering RNA Targeting 14-3-3ζ Increases Efficacy of Chemotherapeutic Agents in Head and Neck Cancer Cells. Molecular Cancer Therapeutics. 9(10). 2676–2688. 24 indexed citations
9.
Ralhan, Ranju, Anthony K.-C. So, S. C. Tripathi, et al.. (2010). Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers. PLoS ONE. 5(11). e14130–e14130. 36 indexed citations
10.
Kaur, Jasbir, Semra Demokan, S. C. Tripathi, et al.. (2010). Promoter hypermethylation in Indian primary oral squamous cell carcinoma. International Journal of Cancer. 127(10). 2367–2373. 44 indexed citations
11.
Tripathi, S. C., Ajay Matta, Jasbir Kaur, et al.. (2010). Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer. PLoS ONE. 5(8). e11939–e11939. 56 indexed citations
12.
Sharma, Gayatri, Sameer Mirza, Rajinder Parshad, et al.. (2010). Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumor Biology. 32(1). 23–32. 34 indexed citations
13.
Matta, Ajay, Ranju Ralhan, Leroi V. DeSouza, & K. W. Michael Siu. (2010). Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery. Mass Spectrometry Reviews. 29(6). 945–961. 44 indexed citations
14.
Matta, Ajay, S. C. Tripathi, Leroi V. DeSouza, et al.. (2009). Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. International Journal of Cancer. 125(6). 1398–1406. 60 indexed citations
15.
Ralhan, Ranju. (2009). Nuclear factor-kappa B links carcinogenic and chemopreventive agents. Frontiers in Bioscience-Elite. 1(1). 45–45. 10 indexed citations
16.
Rohatgi, Nidhi, Ajay Matta, Jasbir Kaur, Anurag Srivastava, & Ranju Ralhan. (2006). Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology. 224(1-2). 1–13. 10 indexed citations
17.
Mathur, Meera, et al.. (2003). Stromelysin‐3 expression is an early event in human oral tumorigenesis. International Journal of Cancer. 107(2). 309–316. 52 indexed citations
18.
Pande, Pankaj, et al.. (2002). Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis. Journal of Cancer Research and Clinical Oncology. 128(6). 336–342. 6 indexed citations
19.
Kaur, Jasbir, Anurag Srivastava, & Ranju Ralhan. (1998). Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity. Oral Oncology. 34(6). 496–501. 64 indexed citations
20.
Mathur, Meera, et al.. (1997). High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.. PubMed. 3(11). 2129–36. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivian Wai Yan Lui Breakdown of academic impact, for papers by Carter Van Waes Breakdown of academic impact, for papers by Zhong Chen Breakdown of academic impact, for papers by M. Radhakrishna Pillai Breakdown of academic impact, for papers by Moulay A. Alaoui‐Jamali Breakdown of academic impact, for papers by Mitsuhiko Osaki Breakdown of academic impact, for papers by Prabhudas S. Patel Breakdown of academic impact, for papers by Alexander T.H. Wu Breakdown of academic impact, for papers by Kaori Shima Breakdown of academic impact, for papers by Pei‐Yi Chu
Rankless by CCL
2026